Gain Therapeutics Inc

NASDAQ:GANX  
2.89
+0.17 (+6.25%)
Earnings Announcements

Gain Therapeutics Reports Full Year 2021 Financial Results

Published: 03/24/2022 12:42 GMT
Gain Therapeutics Inc (GANX) - Gain Therapeutics, Inc. Reports Full Year 2021 Financial Results and Business Update.
Gain Therapeutics Inc - $36.88 Million in Cash As of December 31, 2021, Provides Runway Into Second Half of 2023.
Revenue is expected to be $0.04 Million
Adjusted EPS is expected to be -$0.34

Next Quarter Revenue Guidance is expected to be $0.06 Million
Next Quarter EPS Guidance is expected to be -$0.39

More details on our Analysts Page.